| Report ID | 280997 |
| Drug Identification Number | 02480522 |
| Brand name | XYDALBA |
| Common or Proper name | Xydalba 500mg |
| Company Name | ENDO OPERATIONS LTD. |
| Market Status | MARKETED |
| Active Ingredient(s) | DALBAVANCIN |
| Strength(s) | 500MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 1 vial |
| Anatomical Therapeutical Chemical (ATC) code | J01XA |
| Anatomical Therapeutical Chemical (ATC) description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2026-03-20 |
| Estimated end date | 2026-04-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-04-18 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE, DUBLIN IRELAND D04 H9P8 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2026-04-18 | English | Compare |
| v3 | 2026-03-20 | French | Compare |
| v2 | 2026-03-20 | French | Compare |
| v1 | 2026-03-20 | English | Compare |
Showing 1 to 4 of 4